SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-19-006165
Filing Date
2019-08-14
Accepted
2019-08-14 17:11:30
Documents
43
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT nbse-10q_063019.htm 10-Q 638894
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 14681
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 14467
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 6233
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 6334
  Complete submission text file 0001387131-19-006165.txt   2127464

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT neu-20190630.xml EX-101.INS 232848
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT neu-20190630.xsd EX-101.SCH 20155
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT neu-20190630_cal.xml EX-101.CAL 31722
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT neu-20190630_def.xml EX-101.DEF 84140
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT neu-20190630_lab.xml EX-101.LAB 190448
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT neu-20190630_pre.xml EX-101.PRE 145863
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35963 | Film No.: 191027527
SIC: 2834 Pharmaceutical Preparations